AI Analysis AI Analysis of AMPH AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add AMPH to Watchlist?
  • Easy Tracking In The Watchlist
PDF

On Tuesday, Amphastar Pharmaceuticals stock price gained an impressive 6.55%
(Updated on Jun 23, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Hold candidate since Jun 23, 2026

The Amphastar Pharmaceuticals stock price gained 6.55% on the last trading day (Tuesday, 23rd Jun 2026), rising from $18.33 to $19.53. During the last trading day the stock fluctuated 5.84% from a day low at $18.50 to a day high of $19.58. The price has been going up and down for this period, and there has been a 0.72% gain for the last 2 weeks. Volume fell on the last day by -73 thousand shares and in total, 648 thousand shares were bought and sold for approximately $12.66 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -8.17% during the next 3 months and, with a 90% probability hold a price between $14.73 and $21.13 at the end of this 3-month period.

AMPH Signals & Forecast

The Amphastar Pharmaceuticals stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $19.41 and $19.34. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Thursday, June 11, 2026, and so far it has fallen -4.87%. Further fall is indicated until a new bottom pivot has been found.

Support, Risk & Stop-loss for Amphastar Pharmaceuticals stock

Amphastar Pharmaceuticals finds support from accumulated volume at $19.00 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.08 between high and low, or 5.84%. For the last week, the stock has had daily average volatility of 4.89%.

Our recommended stop-loss: $18.63 (-4.63%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 7 days ago.)

Trading Expectations (AMPH) For The Upcoming Trading Day Of Wednesday 24th

For the upcoming trading day on Wednesday, 24th we expect Amphastar Pharmaceuticals to open at $19.20, and during the day (based on 14 day Average True Range), to move between $19.10 and $19.96, which gives a possible trading interval of +/-$0.86 (+/-4.50%) up or down from last closing price. If Amphastar Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 4.50% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $19.74 (1.08%) than the support at $19.00 (2.71%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Amphastar Pharmaceuticals stock A Buy?

Amphastar Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

Current score: -0.125 Hold/Accumulate Upgraded

Predicted Fair Opening Price

Predicted fair opening price on June 24, 2026 - $19.20 ( 1.67%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

AMPH Performance

Trading levels for AMPH

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 20.28 3.86%
R2 19.87 1.74%
R1 19.62 0.440%
Price 19.53
S1 18.79 -3.79%
S2 18.54 -5.09%
S3 18.12 -7.20%

Accumulated Volume Support & Resistance Levels

Level Price
R3 20.58 5.38%
R2 19.96 2.20%
R1 19.74 1.08%
Price 19.53
S1 19.00 -2.71%
S2 18.81 -3.69%
S3 18.16 -7.01%

AMPH Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jun 07, 2010 Jun 11, 2010 Jun 30, 2010 $0.300 0%
2 Jun 05, 2009 Jun 11, 2009 Jun 30, 2009 $0.300 0%

FAQ

What is the symbol for Amphastar Pharmaceuticals Stock and on which exchange is it traded?
The symbol for Amphastar Pharmaceuticals is AMPH and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Amphastar Pharmaceuticals Stock?
Amphastar Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold candidate.

How to buy Amphastar Pharmaceuticals Stock?
Amphastar Pharmaceuticals Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Amphastar Pharmaceuticals Stock.

What's the current price of Amphastar Pharmaceuticals Stock?
As of the end of day on the Jun 23, 2026, the price of an Amphastar Pharmaceuticals (AMPH) share was $19.53.

What is the 52-week high and low for Amphastar Pharmaceuticals Stock?
The 52-week high for Amphastar Pharmaceuticals Stock is $31.26 and the 52-week low is $16.65.

What is the market capitalization of Amphastar Pharmaceuticals Stock?
As of the Jun 23, 2026, the market capitalization of Amphastar Pharmaceuticals is 861.135M.

When is the next earnings date for Amphastar Pharmaceuticals?
The upcoming earnings date for Amphastar Pharmaceuticals is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT AMPHASTAR PHARMACEUTICALS
Amphastar Pharmaceuticals
Amphastar Pharmaceuticals, Inc., a bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France. The company operates through two segments, Finished Pharmaceutical Products and API. It offers Primatene Mist, an over-the-counter epinephrine inhalation product for the temporary relief of mild symptoms of intermittent asthma; Eno...
GOLDEN STAR
Ticker Change Signal Date
IDYA
$28.98
18.12% Jun 12
DHI
$146.71
6.39% Jun 10
E
ETD
$20.67
4.79% Jun 05
EAT
$140.46
16.94% Jun 05
TPR
$140.47
7.16% Jun 04

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE